| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
disease | 0.300 | None | 0.932 | 12 | 0 | 1999 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.300 | None | 0.936 | 6 | 0 | 2000 | 2019 | ||||||||
|
mucin 16, cell surface associated | 0.479 | 0.808 | 8.3E-112 |
|
disease | 0.100 | None | 0.938 | 2 | 0 | 2004 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
disease | 0.200 | None | 0.952 | 10 | 0 | 1995 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.100 | None | 0.952 | 5 | 0 | 1996 | 2018 | ||||||||
|
cytochrome P450 family 19 subfamily A member 1 | 0.410 | 0.885 | 1.7E-05 |
|
disease | 0.600 | None | 0.956 | 8 | 0 | 1996 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.600 | None | 0.957 | 4 | 0 | 1997 | 2019 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
disease | 0.300 | None | 0.963 | 7 | 0 | 2002 | 2019 | ||||||||
|
progesterone receptor | 0.426 | 0.885 | 5.1E-02 |
|
disease | 0.600 | None | 0.966 | 6 | 0 | 1995 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.976 | 5 | 0 | 1994 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.100 | None | 0.976 | 1 | 0 | 1992 | 2019 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.600 | None | 1.000 | 9 | 0 | 2002 | 2020 | ||||||||
|
estrogen receptor 2 | 0.400 | 0.923 | 4.5E-08 |
|
disease | 0.400 | None | 1.000 | 6 | 0 | 1998 | 2020 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.100 | None | 1.000 | 6 | 0 | 1998 | 2019 | ||||||||
|
interleukin 1 receptor type 2 | 0.593 | 0.846 | 6.5E-15 |
|
disease | 0.080 | None | 1.000 | 6 | 0 | 2002 | 2012 | ||||||||
|
interleukin 1 receptor type 1 | 0.509 | 0.769 | 0.15 |
|
disease | 0.340 | None | 1.000 | 4 | 0 | 2004 | 2011 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 3 | 0 | 2002 | 2019 | ||||||||
|
plasminogen activator, urokinase | 0.425 | 0.923 | 2.3E-06 |
|
disease | 0.040 | None | 1.000 | 3 | 0 | 2003 | 2012 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
disease | 0.090 | None | 1.000 | 3 | 0 | 2004 | 2019 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
disease | 0.060 | None | 1.000 | 3 | 0 | 2002 | 2011 | ||||||||
|
cadherin 1 | 0.401 | 0.808 | 0.15 |
|
disease | 0.080 | None | 1.000 | 3 | 0 | 2002 | 2018 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
aryl-hydrocarbon receptor repressor | 0.666 | 0.577 | 1.8E-04 |
|
disease | 0.040 | None | 1.000 | 2 | 0 | 2001 | 2009 | ||||||||
|
interferon gamma | 0.288 | 0.962 | 0.47 |
|
disease | 0.080 | None | 1.000 | 2 | 0 | 2003 | 2020 | ||||||||
|
matrix metallopeptidase 14 | 0.447 | 0.769 | 1.00 |
|
disease | 0.030 | None | 1.000 | 2 | 0 | 2002 | 2016 |